CAR-Immunotherapy TRIALS
CAR-Immunotherapy package has 22 parameters for all trials registered internationally from 2001 through 30 June 2020, including their current status. Cumulatively, 1036 CAR-Immunotherapy trials have been registered worldwide (see histogram below).
- Trial Data
- Registration Year
- Trial ID with link to trial on-line
- Country
- Phase
- Status (updated as of 17 Sept. 2020)
- Patient Data
- Indication
- Patient Age Groups
- Target Enrollment
- Cell Data
- CAR Target
- Cell Type
- Cell Source
- Donor Type
- CAR Construct (costimulatory domain, vector, etc)
- Cell Dose(s)
- Mode of Administration (route and # doses)
- Conditioning
- Drug Support/Combos
- Sponsor Data
- Academia or Industry Funding
- Sponsor Name
- Study Acronym
- Additional Information
- Product Name
- Notes - includes secondary trial IDs and reasons for termination
Below is a histogram of CAR-Immunotherapy trial numbers versus time, color-coded by trial phase. This illustrates the explosion of CAR-Immunotherapy trials since 2014 and the appearance of follow-up studies since 2015. During 2019, 33% of new CAR-Immunotherapy trials were not registered in ClinicalTrials.gov.
Attachment | Size |
---|---|
![]() | 12.19 KB |